352 related articles for article (PubMed ID: 33671985)
1. Tryptophan Metabolism via Kynurenine Pathway: Role in Solid Organ Transplantation.
Zulpaite R; Miknevicius P; Leber B; Strupas K; Stiegler P; Schemmer P
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671985
[TBL] [Abstract][Full Text] [Related]
2. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.
Brandacher G; Margreiter R; Fuchs D
Curr Drug Metab; 2007 Apr; 8(3):273-82. PubMed ID: 17430115
[TBL] [Abstract][Full Text] [Related]
3. Regulation of indoleamine 2,3 dioxygenase and its role in a porcine model of acute kidney allograft rejection.
Wang Y; Merchen TD; Fang X; Lassiter R; Ho CS; Jajosky R; Kleven D; Thompson T; Mohamed E; Yu M; Waller JL; Nahman NS
J Investig Med; 2018 Dec; 66(8):1109-1117. PubMed ID: 30006478
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
5. Tissue metabolic profiling shows that saccharopine accumulates during renal ischemic-reperfusion injury, while kynurenine and itaconate accumulate in renal allograft rejection.
Beier UH; Hartung EA; Concors S; Hernandez PT; Wang Z; Perry C; Baur JA; Denburg MR; Hancock WW; Gade TP; Levine MH
Metabolomics; 2020 May; 16(5):65. PubMed ID: 32367163
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase inhibition alters the non-coding RNA transcriptome following renal ischemia-reperfusion injury.
Merchen TD; Boesen EI; Gardner JR; Harbarger R; Kitamura E; Mellor A; Pollock DM; Ghaffari A; Podolsky R; Nahman NS
Transpl Immunol; 2014 May; 30(4):140-4. PubMed ID: 24751756
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
[TBL] [Abstract][Full Text] [Related]
8. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
Baumgartner R; Forteza MJ; Ketelhuth DFJ
Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580
[TBL] [Abstract][Full Text] [Related]
9. [EFFECTS OF INDOLEAMINE 2, 3-DIOXYGENASE GENE MODIFIED BONE MARROW MESENCHYMAL STEM CELLS IN RAT COMPOSITE TISSUE ALLOGRAFT REJECTION].
Han F; Wang Y; Wang Y; Jia Y; Yang L; Jia W; Fang X; Bai X; Hu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):745-51. PubMed ID: 26455230
[TBL] [Abstract][Full Text] [Related]
10. Anti-infectious activity of tryptophan metabolites in the L-tryptophan-L-kynurenine pathway.
Narui K; Noguchi N; Saito A; Kakimi K; Motomura N; Kubo K; Takamoto S; Sasatsu M
Biol Pharm Bull; 2009 Jan; 32(1):41-4. PubMed ID: 19122278
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.
Strasser B; Becker K; Fuchs D; Gostner JM
Neuropharmacology; 2017 Jan; 112(Pt B):286-296. PubMed ID: 26924709
[TBL] [Abstract][Full Text] [Related]
12. Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes.
Strasser B; Geiger D; Schauer M; Gatterer H; Burtscher M; Fuchs D
PLoS One; 2016; 11(4):e0153617. PubMed ID: 27124720
[TBL] [Abstract][Full Text] [Related]
13. Systemic metabolism of tryptophan and its catabolites, kynurenine and 3-HAA, in mice with inflammatory arthritis.
Kolodziej L
Gene; 2013 Jan; 512(1):23-7. PubMed ID: 23063938
[TBL] [Abstract][Full Text] [Related]
14. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.
Bauer TM; Jiga LP; Chuang JJ; Randazzo M; Opelz G; Terness P
Transpl Int; 2005 Jan; 18(1):95-100. PubMed ID: 15612990
[TBL] [Abstract][Full Text] [Related]
15. A validated surrogate analyte LC-MS/MS assay for quantitation of endogenous kynurenine and tryptophan in human plasma.
Miller D; Tan L; Dorshorst D; Morrissey K; Mahrus S; Milanowski D; McKnight J; Cape S; Dean B; Liang X
Bioanalysis; 2018 Aug; 10(16):1307-1317. PubMed ID: 30141341
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3 Dioxygenase 1-The Potential Link between the Innate Immunity and the Ischemia-Reperfusion-Induced Acute Kidney Injury?
Krupa A; Krupa MM; Pawlak K
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682852
[TBL] [Abstract][Full Text] [Related]
17. Improved Radiosynthesis and Biological Evaluations of L- and D-1-[
Xin Y; Cai H
Mol Imaging Biol; 2017 Aug; 19(4):589-598. PubMed ID: 27815661
[TBL] [Abstract][Full Text] [Related]
18. Causes and prognostic value of pre-transplant elevated kynurenine level in kidney allograft recipients.
Kaden J; Abendroth D; Völp A; Marzinzig M; Wesslau C
Ann Transplant; 2014 Jan; 19():51-9. PubMed ID: 24463770
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase.
Landfried K; Zhu W; Waldhier MC; Schulz U; Ammer J; Holler B; Wolff D; Edinger M; Peter K; Kreutz M; Andreesen R; Oefner PJ; Holler E
Blood; 2011 Dec; 118(26):6971-4. PubMed ID: 22039265
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
